These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 10695398)

  • 1. [Sustained long-term complete remission in an elderly aplastic anemia patient after cessation of combined therapy consisting of granulocyte-colony stimulating factor and erythropoietin].
    Yasuyama M; Kawauchi K; Sugiyama H; Ohkawa S
    Rinsho Ketsueki; 2000 Jan; 41(1):42-7. PubMed ID: 10695398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trilineage recovery by combination therapy with recombinant human granulocyte colony-stimulating factor and erythropoietin in patients with aplastic anemia and refractory anemia.
    Bessho M; Jinnai I; Hirashima K; Saito M; Murohashi I; Ino H; Tsuji M; Fukuda M; Maruyama M; Kusumoto S
    Stem Cells; 1994 Nov; 12(6):604-15. PubMed ID: 7533579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aplastic anemia successfully treated with erythropoietin and rhG-CSF].
    Higashino K; Kito K; Hodohara K; Fujiyama Y; Banba T; Hosoda S
    Rinsho Ketsueki; 1992 Sep; 33(9):1237-41. PubMed ID: 1279235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Successful combined therapy with ATG, cyclosporin and G-CSF for both liver dysfunction and bone marrow failure in hepatitis-associated aplastic anemia].
    Adachi Y; Usuki K; Kazama H; Iki S; Matsuya S; Urabe A
    Rinsho Ketsueki; 2001 Sep; 42(9):691-5. PubMed ID: 11680980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
    Musto P; Sanpaolo G; D'Arena G; Scalzulli PR; Matera R; Falcone A; Bodenizza C; Perla G; Carotenuto M
    Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Two patients with aplastic anemia successfully treated with G-CSF and erythropoietin].
    Hanamura A; Ichikawa A; Utsumi M; Hotta T
    Rinsho Ketsueki; 1995 Dec; 36(12):1347-52. PubMed ID: 8587170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy with rhGM-CSF and rhEpo for two patients with refractory anemia and aplastic anemia.
    Takahashi M; Aoki A; Mito M; Nikkuni K; Ohtsuka T; Saitoh H; Moriyama Y; Shibata A
    Hematol Pathol; 1993; 7(3):153-8. PubMed ID: 8244908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy with G-CSF and erythropoietin after autologous bone marrow transplantation for lymphoid malignancies: a randomized trial.
    Vannucchi AM; Bosi A; Ieri A; Guidi S; Saccardi R; Lombardini L; Linari S; Laszlo D; Longo G; Rossi-Ferrini P
    Bone Marrow Transplant; 1996 Apr; 17(4):527-31. PubMed ID: 8722349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of refractory anemia with a combination regimen containing recombinant human erythropoietin, low-dose methylprednisolone and nandrolone.
    Tsiara SN; Chaidos A; Gouva M; Christou L; Panteli K; Kapsali E; Bourantas KL
    J Exp Clin Cancer Res; 2004 Mar; 23(1):47-52. PubMed ID: 15149150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery of hematopoietic progenitor cells in patients with severe aplastic anemia who obtained good clinical response with a combination therapy of immunosuppressive agents and recombinant human granulocyte colony-stimulating factor.
    Matsuo Y; Iwanaga M; Mori H; Yoshida S; Kawaguchi Y; Yakata Y; Murata K; Nagai K; Jinnai I; Matsuo T; Kuriyama K; Tomonaga M
    Int J Hematol; 2000 Jul; 72(1):37-43. PubMed ID: 10979207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin plus granulocyte colony-stimulating factor in the treatment of myelodysplastic syndromes. Identification of a subgroup of responders. The Spanish Erythropathology Group.
    Remacha AF; Arrizabalaga B; Villegas A; Manteiga R; Calvo T; Julià A; Fernández Fuertes I; González FA; Font L; Juncà J; del Arco A; Malcorra JJ; Equiza EP; de Mendiguren BP; Romero M
    Haematologica; 1999 Dec; 84(12):1058-64. PubMed ID: 10586205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study.
    Locasciulli A; Bruno B; Rambaldi A; Saracco P; Dufour C; Finelli C; Sica S; Varotto S; Arcese W; Locatelli F; Soligo D; Bacigalupo A;
    Haematologica; 2004 Sep; 89(9):1054-61. PubMed ID: 15377466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Streptomycin-induced severe aplastic anemia successfully treated with high-dose methylprednisolone pulse therapy and rhG-CSF].
    Umeno Y; Miyamoto Y; Ohta Y
    Rinsho Ketsueki; 1993 Nov; 34(11):1491-3. PubMed ID: 7504752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multilineage response in aplastic anemia patients following long-term administration of filgrastim (recombinant human granulocyte colony stimulating factor).
    Sonoda Y; Ohno Y; Fujii H; Takahashi T; Nakayama S; Haruyama H; Nasu K; Shimazaki C; Hara H; Kanamaru A
    Stem Cells; 1993 Nov; 11(6):543-54. PubMed ID: 7509223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transformation of aplastic anemia to acute myeloid leukemia with myelofibrosis following treatment with granulocyte colony-stimulating factor and erythropoietin].
    Tsurumi H; Yamada T; Hara T; Murakami N; Moriwaki H; Muto Y
    Rinsho Ketsueki; 1996 Jul; 37(7):630-2. PubMed ID: 8779784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interleukin-3 therapy in patients with aplastic anemia refractory to prior therapies].
    Miyairi Y; Murai K; Utsugisawa T; Narigasawa Y; Ito S; Shimosegawa K; Sugawara T; Numaoka H; Ono Y; Ito T; Ishida Y; Kuriya S
    Rinsho Ketsueki; 1996 Jan; 37(1):22-8. PubMed ID: 8683863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of acquired severe aplastic anemia with antilymphocyte globulin, cyclosporin A, methyprednisolone, and granulocyte colony-stimulating factor.
    Dinçol G; Aktan M; Diz-Küçükkaya R; Yavuz S; Nalçaci M; Oztürk S; Palanduz S; Doğan O; Ağan M
    Am J Hematol; 2007 Sep; 82(9):783-6. PubMed ID: 17506070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined use of erythropoietin and granulocyte colony-stimulating factor does not decrease blood transfusion requirements during induction therapy for high-risk neuroblastoma: a randomized controlled trial.
    Wagner LM; Billups CA; Furman WL; Rao BN; Santana VM
    J Clin Oncol; 2004 May; 22(10):1886-93. PubMed ID: 15143081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Time course changes in the count of peripheral granulocytes in children with acquired aplastic anemias treated with antithymocyte globulin, cyclosporin A and granulocytic colony stimulating factor].
    Bogacheva NIu; Novichkova GA; Litvinov DV; Khachatrian LA; Baĭdil'dina DD; Shneĭder MM; Suntsova EV; Skorobogatova EV; Maschan AA
    Ter Arkh; 2002; 74(12):71-7. PubMed ID: 12577848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.